These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14508120)

  • 1. New paradigms for cancer drug discovery.
    Sager JA; Lengauer C
    Cancer Biol Ther; 2003; 2(4):452-5. PubMed ID: 14508120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New paradigms for cancer drug discovery.
    Sager JA; Lengauer C
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S178-81. PubMed ID: 14508097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why is big Pharma getting out of antibacterial drug discovery?
    Projan SJ
    Curr Opin Microbiol; 2003 Oct; 6(5):427-30. PubMed ID: 14572532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prince and the pauper. A tale of anticancer targeted agents.
    Dueñas-González A; García-López P; Herrera LA; Medina-Franco JL; González-Fierro A; Candelaria M
    Mol Cancer; 2008 Oct; 7():82. PubMed ID: 18947424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partnership between small biotech and big pharma.
    Wiederrecht GJ; Hill RG; Beer MS
    IDrugs; 2006 Aug; 9(8):560-4. PubMed ID: 16871465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedicine. Pharma firms push for sharing of cancer trial data.
    Bhattacharjee Y
    Science; 2012 Oct; 338(6103):29. PubMed ID: 23042862
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial drug discovery: is small pharma the solution?
    Boggs AF; Miller GH
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-boundary cancer studies at the University of Tokyo: Opening a path through research to the future of cancer treatment.
    Noda T
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i43-47. PubMed ID: 24516212
    [No Abstract]   [Full Text] [Related]  

  • 9. Discontinued drugs in 2010: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
    Ekimoto H
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The state of innovation in drug development.
    Kola I
    Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of natural product chemistry in drug discovery.
    Butler MS
    J Nat Prod; 2004 Dec; 67(12):2141-53. PubMed ID: 15620274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and economic trends in cancer therapeutic drugs in the UK from 1955 to 2009.
    Savage P
    J Oncol Pharm Pract; 2012 Mar; 18(1):52-6. PubMed ID: 21109615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial drug discovery: is it all downhill from here?
    Projan SJ; Shlaes DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pursuit of personalized anticancer therapy: leveraging collaboration between academia and the biotech/pharmaceutical industry.
    Buck E; Mulvihill M; Iwata KK
    Mt Sinai J Med; 2010; 77(4):358-65. PubMed ID: 20687181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partnership between academia and industry for drug discovery in Alzheimer's disease.
    Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
    Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.